ShareValue.ai

ShareValue scores for 300109.SHE: Valuation 41, Quality 69, Growth 28, Health 59.

300109.SHE
SZSE

Boai NKY Pharmaceuticals Ltd

CN¥14.20(-1.46%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 14%
Valuation
41
Fair Value
Price vs Value
Quality
69
Moderate
Business Strength
Growth
28
Weak
Revenue & Earnings
Health
59
Moderate
Financial Stability
Momentum
72
Bullish
Price Trend

Company Details

About

Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP) series products, vinyl methyl ether/maleic anhydride copolymer (PVM/MA, Euroster) copolymer, and oral care products; and medical technology services, such as early tumor screening, molecular diagnostics, and precision medicine. It also offers pharmaceutical; hazardous chemical; food additive; medical protective equipment; medical device; manufacturing of basic chemical raw materials; import and export of goods and technology; technical services; and technology development, consulting, exchange, transfer, and promotion. The company was formerly known as Boai NKY Pharmaceuticals Ltd. and changed its name to Boai NKY Medical Holdings Ltd. in March 2016. Boai NKY Medical Holdings Ltd. was founded in 1987 and is based in Jiaozuo, China.

Score Analysis

AI Investment Thesis

Data as of:Jul 9, 2026
|
Last calculated:Jul 9, 2026